GSK:NYSE
GSK plc
49,89Â US$
arrow_downward
-1,93%(-0,98) 1D
49,91Â US$
arrow_upward
+0,04% (+0,020)bedtimeJashtë orarit
Mbyllur: 4 sht, 4:00:03 m.d., GMT-4 · USD
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për GSK...
Hap
49,70Â US$
I lartë
50,06Â US$
I ulët
49,66Â US$
Kapitalizimi i tregut
99,85Â mld
Vëllimi mesatar
3,63Â mln
Vëllimi
2,29Â mln
Dividendi
3,64%
Dividendi tremujor
0,45Â US$
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
15,68
Maksimumi 52-javor
61,70Â US$
Minimumi 52-javor
39,29Â US$
Fitimet për aksion
3,18Â US$
Beta
0,27
Aksionet në qarkullim
2,02Â mld
Numri i punonjësve
67 mijë
Hap
49,70Â US$
I lartë
50,06Â US$
I ulët
49,66Â US$
Kapitalizimi i tregut
99,85Â mld
Vëllimi mesatar
3,63Â mln
Vëllimi
2,29Â mln
Dividendi
3,64%
Dividendi tremujor
0,45Â US$
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
15,68
Maksimumi 52-javor
61,70Â US$
Minimumi 52-javor
39,29Â US$
Fitimet për aksion
3,18Â US$
Beta
0,27
Aksionet në qarkullim
2,02Â mld
Numri i punonjësve
67 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
18 orë më parë
HCM stock gains on GSK oncology deal and fresh guidance
Benzinga
·
1 ditë më parë
Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Report
AD HOC NEWS
·
1 ditë më parë
GSK stock gains support from licensing deal and solid first-half growth
Benzinga
·
2 ditë më parë
Why Is HUTCHMED Stock Soaring Thursday?
Profili
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Rreth GSK plc
Drejtori ekzekutivEmma Walmsley | Emma Walmsley
Punonjësit66,8 mijë
Themeluar më27 dhj 2000
Selia-
Sektori-
Uebsajtigsk.com